AbbVie’s ABBV 2024 revenue grew 4.6% on a constant currency basis, with 2025 guidance of 5.7% growth and new 2027 guidance for combined sales of immunology drug Skyrizi and Rinvoq of $31 billion (up ...

With that being said, let’s move to the 10 best stocks for beginners with little money according to hedge funds.

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

The health tech company formerly known as Allscripts, still reeling from failing to fix its financial reports, will have to go it alone.

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...

These healthcare REITs are rated Buy at Jefferies and make sense now for investors seeking dependable passive income and a ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a ...

The final move, made by Larry Culp, was to break GE into three businesses: GE Verona, GE Healthcare , and GE Aerospace. The ...

We recently published a list of 10 AI News and Ratings Too Important to Miss. In this article, we are going to take a look at where GE HealthCare Technologies Inc.

European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.